ABSTRACT
BACKGROUND: Melanomas, a highly malignant tumor of the skin, have no effective therapy to date. OBJECTIVE: To review the melanoma stem cell markers identified and existing therapies. METHODS: We retrieved database of CNKI and PubMed for articles addressing melanoma stem cell markers and targeted therapies, which were published from January 2010 to December 2016. The key words were"melanoma, cancer stem cell, marker, therapy" in Chinese and English, respectively. RESULTS AND CONCLUSION: Forty articles were included in the final review. It is important to separate cancer stem cells from tumor cells by tumor stem cell markers for the study of tumor growth, recurrence, metastasis and drug resistance. There are still no generally recognized markers of melanoma stem cells, but the generally studied markers are CD20, CD133, CD271, ABCB5 and SOX10. To date, we have a poor understanding of melanoma stem cell markers, and further investigations on the markers and targeted therapies are warranted.
ABSTRACT
Objective To determine the effect of photochemotherapy on the expression of gelatinases. Methods Reverse transcription-polymerase chain reaction and gelatine zymography were employed to detect the effect of photochemotherapy on the expression and bioactivity of gelatinases at mRNA and protein levels respectively. Results Combination of ultraviolet A(UVA,0.8-2.0 J/cm2) and 8-methoxypsoralen(8-MOP,100 ng/mL) resulted in a decrease in the expression and bioactivity of gelatinases. Conclusion Photochemotherapy can inhibit the angiogenesis of endothelial cells through downregulating the expression and bioactivity of gelatinases.